|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_on1159162541 |
| 003 |
OCoLC |
| 005 |
20231120010457.0 |
| 006 |
m o d |
| 007 |
cr un|---aucuu |
| 008 |
200620s2020 ne o 001 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDX
|d OPELS
|d UKAHL
|d OCLCF
|d UKMGB
|d N$T
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|
| 015 |
|
|
|a GBC075827
|2 bnb
|
| 016 |
7 |
|
|a 019819556
|2 Uk
|
| 019 |
|
|
|a 1159206835
|
| 020 |
|
|
|a 0081029861
|
| 020 |
|
|
|a 9780081029862
|q (electronic bk.)
|
| 020 |
|
|
|z 9780081029855
|
| 020 |
|
|
|z 0081029853
|
| 035 |
|
|
|a (OCoLC)1159162541
|z (OCoLC)1159206835
|
| 050 |
|
4 |
|a R857.M3
|
| 082 |
0 |
4 |
|a 610.28
|2 23
|
| 245 |
0 |
0 |
|a Nanoengineered biomaterials for advanced drug delivery /
|c edited by Masoud Mozafari.
|
| 260 |
|
|
|a Amsterdam :
|b Elsevier,
|c 2020.
|
| 300 |
|
|
|a 1 online resource (826 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Woodhead Publishing Series in Biomaterials
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Intro -- Nanoengineered Biomaterials for Advanced Drug Delivery -- Copyright -- Contents -- Contributors -- Preface -- Acknowledgment -- Part One Principles of nanotechnology-based drug delivery -- 1 Principles of nanosized drug delivery systems -- 1.1 Introduction -- 1.2 What are nanosized drug delivery systems and why they are useful? -- 1.3 Different types of nanodelivery systems -- 1.3.1 Polymeric nanoparticles -- 1.3.2 Liposomes -- 1.3.3 Niosomes -- 1.3.4 Solid lipid nanoparticles -- 1.3.5 Micro- and nanoemulsions -- 1.3.6 Polymeric micelles -- 1.3.7 Dendrimers
|
| 505 |
8 |
|
|a 1.3.8 Inorganic nanoparticles and quantum dots -- 1.3.9 Nanocrystals -- 1.3.10 Protein-based and natural biopolymer-based nanoparticles -- 1.4 Particle properties and related biobarrier interactions of nanosystems -- 1.4.1 Opsonization and phagocytosis -- 1.4.2 Particle size -- 1.4.3 Shape -- 1.4.4 Surface charge -- 1.4.5 Hydrophilic/hydrophobic character -- 1.4.6 Other factors -- 1.5 Nanoparticles in medicines -- 1.5.1 Lipid nanotechnology -- 1.5.2 Nanoparticle nanotechnology -- 1.6 Conclusions -- References -- 2 Controlled/localized release and nanotechnology -- 2.1 Introduction
|
| 505 |
8 |
|
|a 2.2 The evolution of drug delivery systems -- 2.3 Nanostructures from dimension viewpoint -- 2.3.1 Zero-dimensional nanostructures -- 2.3.2 One-dimensional nanostructures -- 2.3.3 Two-dimensional nanostructures -- 2.3.4 Three-dimensional nanostructures -- 2.4 Bionanostructures -- 2.5 Micro- and nanomotors -- 2.6 Conclusion -- References -- 3 Stimuli-sensitive drug delivery systems -- 3.1 Introduction -- 3.2 pH-sensitive drug delivery systems -- 3.3 Redox-sensitive drug delivery systems -- 3.4 Thermosensitive drug delivery systems -- 3.5 Magnetically sensitive drug delivery systems
|
| 505 |
8 |
|
|a 3.6 Ultrasound-sensitive drug delivery systems -- 3.7 Photosensitive drug delivery systems -- 3.8 Electrosensitive drug delivery systems -- 3.8.1 Intrinsically conducting polymers -- 3.8.2 Hydrogels -- 3.9 Enzyme-sensitive drug delivery systems -- 3.10 Dual- and multisensitive drug delivery systems -- 3.11 Conclusions -- References -- 4 Sustainable drug delivery systems through green nanotechnology -- 4.1 Nanotechnology -- 4.2 Green nanotechnology -- 4.3 Green nanotechnology in drug delivery -- 4.4 Classification of nanoparticles -- 4.4.1 Liposomes -- 4.4.2 Polymeric nanoparticles
|
| 505 |
8 |
|
|a 4.4.3 Dendrimer -- 4.4.4 Quantum dots -- 4.4.5 Silica nanoparticles -- 4.4.6 Magnetic nanoparticles -- 4.5 Metal-organic frameworks -- 4.6 Green methods for synthesis of MOFs -- 4.6.1 Mechanochemistry -- 4.6.2 Sonochemistry -- 4.6.3 Microwave -- 4.7 Synthesis of MOFs by using bioactive molecules -- 4.8 Summary -- References -- Further reading -- 5 Recent advances in multifunctional nanoengineered biomaterials -- 5.1 Introduction -- 5.2 Recent advances in imaging techniques -- 5.2.1 Optical imaging -- 5.2.2 Photoacoustic imaging -- 5.2.3 Multimodality imaging
|
| 500 |
|
|
|a 5.3 Recent advances in biomedical applications
|
| 500 |
|
|
|a Includes index.
|
| 650 |
|
0 |
|a Nanostructured materials.
|
| 650 |
|
0 |
|a Biomedical materials.
|
| 650 |
|
0 |
|a Drug delivery systems.
|
| 650 |
|
2 |
|a Nanostructures
|0 (DNLM)D049329
|
| 650 |
|
2 |
|a Biocompatible Materials
|0 (DNLM)D001672
|
| 650 |
|
2 |
|a Biomedical and Dental Materials
|0 (DNLM)D001697
|
| 650 |
|
2 |
|a Drug Delivery Systems
|0 (DNLM)D016503
|
| 650 |
|
6 |
|a Nanomat�eriaux.
|0 (CaQQLa)201-0258061
|
| 650 |
|
6 |
|a Biomat�eriaux.
|0 (CaQQLa)201-0025723
|
| 650 |
|
6 |
|a Syst�emes d'administration de m�edicaments.
|0 (CaQQLa)000260397
|
| 650 |
|
7 |
|a Biomedical materials
|2 fast
|0 (OCoLC)fst00832586
|
| 650 |
|
7 |
|a Drug delivery systems
|2 fast
|0 (OCoLC)fst00898667
|
| 650 |
|
7 |
|a Nanostructured materials
|2 fast
|0 (OCoLC)fst01032630
|
| 700 |
1 |
|
|a Mozafari, Masoud.
|
| 776 |
0 |
8 |
|i Print version:
|a Mozafari, Masoud.
|t Nanoengineered Biomaterials for Advanced Drug Delivery.
|d San Diego : Elsevier, �2020
|
| 830 |
|
0 |
|a Woodhead Publishing series in biomaterials.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780081029855
|z Texto completo
|
